Researchers, Clinicians and Patients: Submit a Manuscript on ME to WORK Journal

Researchers, patients and clinicians are invited to submit a manuscript for consideration in a special issue of WORK: A Journal of Prevention, Assessment and Rehabilitation (IOS Press), which will focus exclusively on the area of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Submissions are due Sept. 13, 2019.

Scope

The focus of this special edition is to examine how the concept of work is redefined by the disease process of ME/CFS. Work is central to the identity and sense of competence of each individual, group and population (American Occupational Therapy Association, 2014).

Individuals living with ME/CFS have a unique perspective on work as a result of the challenges brought about by the disease. To shed light on this unique and particularly challenging relationship between ME/CFS and work, this issue will seek to investigate and demonstrate what “work” looks like from a biological to individual to community perspective.

Manuscripts are encouraged, but not exclusive, in the following areas:

Research of the disease process and biological effects

Studies identifying the disease burden on individual to society levels

Scientific reviews, therapeutic interventions, case studies, personal stories

Submission Format

A variety of presentation styles will be accepted:

  • Research and clinical papers (15-30 double spaced pages)
  • Literature reviews and surveys (20-30 double spaced pages)
  • Case studies (3-10 double spaced pages)

All submissions must be in electronic format using Microsoft Word or PDF, in at least 11-point Arial font. References must be listed in Vancouver style, placing citations as numbers in square brackets in the text. Please review the submission for correctness prior to sending it: https://www.iospress.nl/journal/work/

Include the following information on the cover page:

  1. Corresponding author’s name, phone, fax, email and mail address
  2. Title of paper
  3. Names and full affiliations of all authors
  4. A brief abstract (max 200 words)
  5. Keywords
  6. Date

Accepted articles will have open accessand will be freely available from the moment it is published. Guest editors will offer initial feedback and suggested revisions with blind peer review to follow.

All submissions must be sent directly to Amy Mooney at [email protected]

Additional information about the journal, including detailed instructions for authors can be found at the WORK website: https://www.iospress.nl/journal/work/

Important Dates

Submission Deadline: September 13, 2019

Acceptance notification and revised manuscripts returned to author: November 2019

Revised manuscript due back to editor: January 13, 20

Special Issue anticipated publication date: TBD

Facebook
Twitter
WhatsApp
Email

Latest News

Text across top of image reads: "Experts in infection associated chronic illness" with "WE WANT YOU!" bolded below it. Hand with finger pointed out at viewer. "Apply now" buttons to the left and right with mouse cursor clicking on them.

Infection-associated chronic disease experts needed at ARPA-H

Congress launched ARPA-H (the Advanced Research Projects Agency for Health) this past March to focus on high-risk, high-reward research projects with the goal to solve intractable health problems. As ARPA-H is in the process of hiring its first cohort of program managers, #MEAction and a coalition of chronic disease advocacy groups have published an open

Read More »

BOLD ACTION is a Commitment to Healthcare Justice for People with ME

BOLD ACTION to me, means mobilizing our community to publicly demonstrate our deep and intense—as opposed to shallow and passive—commitment to seeing healthcare justice for people with ME. It is about bringing our issues to the forefront of public consciousness and putting strong pressure on our leaders to act. Taking BOLD ACTION is both a

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top